Cartilage Degeneration Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Cartilage Degeneration Market: By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Type of Treatment (Palliative, Intrinsic Repair Stimulus), By Site of Action (Knee Cartilage Repair), By End User (Hospitals, Diagnostic centres, Orthopaedic Hospitals, Ambulatory surgical centres), By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Cartilage Degeneration Market size is valued at USD 13,926.2 million in 2021 and is expected to grow at a CAGR of 5.9% during the forecast period 2022 to 2028. The global market provides a detailed overview and which can be segmented by treatment modality, application, type of treatment, site of action, end user, and region. By treatment modality, the cartilage degeneration market has been segmented into cell-based, and non-cell-based. By treatment modality, the cell-based segment held the largest revenue share of the cartilage degeneration market in past years and is expected to have the fastest growth rate over the forecasted period due rise in cartilage degeneration among various aged people which leads to enhances demand for cell-based cartilage treatment. By application, the Cartilage degeneration market has been segmented into hyaline cartilage and fibrocartilage. By application, the fibrocartilage segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to a high prescription rate. By type of treatment, the Cartilage degeneration market has been segmented into palliative and intrinsic repair stimuli. By the site of action, the cartilage degeneration market has been segmented into knee cartilage repair. The knee segment accounted for the highest share of the market. The growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to a study published in an online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed a massive growth of around 40.0% during the past 4 decades. Furthermore, increasing awareness of the benefits provided by cartilage repair is also anticipated to drive the growth of the knee segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, orthopedic hospitals, and ambulatory surgical centers. The ambulatory surgical clinic segment held the largest share of the market in 2019. Also, the segment is expected to register the highest CAGR in the market during the forecast period.

Key Development:

In Jan 2021, New Treatment Target was discovered that halts osteoarthritis-like knee cartilage degeneration.

Cartilage Degeneration Market

MARKET SUMMARY
-
5.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.9%
  • Largest Market– North America
  • Fastest Growing Market– Asia pacific

Cartilage Degeneration Market

  • The global cartilage degeneration market report gives comprehensive outlook on cartilage degeneration across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global cartilage degeneration gives historical, current, and future market sizes (US$ Mn) on the basis of treatment modality, application, type of treatment, end user and region.
Key Players
  • Zimmer Biomet Holdings, Inc. (U.S.)
  • Vericel Corporation (U.S.)
  • Smith & Nephew plc (U.K.)
  • Osiris Therapeutics, Inc. (U.S.)
  • Arthrex Inc. (U.S.).
Cartilage Degeneration Market Drivers

Obesity has a substantial effect on the musculoskeletal system, resulting in the degeneration of bones, cartilage, and ligaments. Furthermore, the condition, along with other prominent factors, is strongly related to the increased risk of rapid cartilage loss. The increasing prevalence of obesity is anticipated to accelerate the incidence of cartilage degeneration, which will further drive market growth.


North-America Got Significant Share

Cartilage Degeneration Market

North America market is expected to witness the highest market share during the forecast period of rising obesity cases among a mass population. For instance, according to a study published by the Centers for Disease Control and Prevention, the prevalence of obesity has grown from 30.5% to 42.4% during the past two decades in the US. Overweight conditions among players and athletes can further lead to the increasing prevalence of sports injuries.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

Cartilage Degeneration Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The major factors driving the market growth are increasing number of sports injuries, and the rising prevalence of obesity.

The global Cartilage degeneration market size is valued at USD 13,926.2 million in 2021 and is expected to grow at a CAGR of 5.9% during the forecast period 2022 to 2028.

North America dominated the global cartilage degeneration market and held a significant market share, and would expand to dominate the global market by making huge investments in healthcare sectors.

Product launches and acquisitions are the two key strategies opted by the leading companies in the market.


Report

Table Of Content


Report

Company Profile

  • Zimmer Biomet Holdings, Inc. (U.S.)
  • Vericel Corporation (U.S.)
  • Smith & Nephew plc (U.K.)
  • Osiris Therapeutics, Inc. (U.S.)
  • Arthrex Inc. (U.S.).

Description

Cartilage Degeneration Market size is valued at USD 13,926.2 million in 2021 and is expected to grow at a CAGR of 5.9% during the forecast period 2022 to 2028. The global market provides a detailed overview and which can be segmented by treatment modality, application, type of treatment, site of action, end user, and region. By treatment modality, the cartilage degeneration market has been segmented into cell-based, and non-cell-based. By treatment modality, the cell-based segment held the largest revenue share of the cartilage degeneration market in past years and is expected to have the fastest growth rate over the forecasted period due rise in cartilage degeneration among various aged people which leads to enhances demand for cell-based cartilage treatment. By application, the Cartilage degeneration market has been segmented into hyaline cartilage and fibrocartilage. By application, the fibrocartilage segment held the largest revenue share of the gastric cancer therapy market in past years and is expected to have the fastest growth rate over the forecasted period due to a high prescription rate. By type of treatment, the Cartilage degeneration market has been segmented into palliative and intrinsic repair stimuli. By the site of action, the cartilage degeneration market has been segmented into knee cartilage repair. The knee segment accounted for the highest share of the market. The growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to a study published in an online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed a massive growth of around 40.0% during the past 4 decades. Furthermore, increasing awareness of the benefits provided by cartilage repair is also anticipated to drive the growth of the knee segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, orthopedic hospitals, and ambulatory surgical centers. The ambulatory surgical clinic segment held the largest share of the market in 2019. Also, the segment is expected to register the highest CAGR in the market during the forecast period.

Key Development:

In Jan 2021, New Treatment Target was discovered that halts osteoarthritis-like knee cartilage degeneration.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX